BriaCell to Present Bria-OTS+™ Preclinical Data at SITC 2025 Annual Meeting
Globenewswire·2025-10-03 11:30
Core Insights - BriaCell Therapeutics Corp. will present preclinical data on Bria-OTS+ at the Society for Immunotherapy of Cancer (SITC) 40th Anniversary Annual Meeting from November 7-9, 2025 [1][2] Company Overview - BriaCell is a clinical-stage biotechnology company focused on developing novel immunotherapies aimed at transforming cancer care [3]